Form 10-Q GoodRx Holdings, Inc. For: Mar 31

Go back to Form 10-Q GoodRx Holdings, Inc. For: Mar 31

GoodRx Holdings Inc. (GDRX) PT Lowered to $8 at Deutsche Bank

May 13, 2024 5:49 AM EDT

Deutsche Bank analyst George Hill lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $8.00 (from $9.00) while maintaining a Hold rating.

The analyst comments "Modest Q1 Beat With Continued Margin Expansion: GDRX reported solid Q1 results with modest revenue beat and better-than-expected... More

TD Cowen Reiterates Buy Rating on GoodRx Holdings Inc. (GDRX)

May 9, 2024 4:01 PM EDT

TD Cowen analyst Charles Rhyee reiterated a Buy rating and $14.00 price target on GoodRx Holdings Inc. (NASDAQ: GDRX)

The analyst comments "We update our model following 1Q24 results, where mgmt. raised its 2024 guidance for revenue to $800-$810M (from ~$800M) and adj.... More